AU631755B2 - Antidepressant - Google Patents

Antidepressant Download PDF

Info

Publication number
AU631755B2
AU631755B2 AU90109/91A AU9010991A AU631755B2 AU 631755 B2 AU631755 B2 AU 631755B2 AU 90109/91 A AU90109/91 A AU 90109/91A AU 9010991 A AU9010991 A AU 9010991A AU 631755 B2 AU631755 B2 AU 631755B2
Authority
AU
Australia
Prior art keywords
weeks
nicotinamide
adenine
dinucleotide
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU90109/91A
Other languages
English (en)
Other versions
AU9010991A (en
Inventor
Jorg Birkmayer
Walther Birkmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU9010991A publication Critical patent/AU9010991A/en
Application granted granted Critical
Publication of AU631755B2 publication Critical patent/AU631755B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AU90109/91A 1991-01-04 1991-12-31 Antidepressant Ceased AU631755B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4100361A DE4100361C1 (enExample) 1991-01-04 1991-01-04
DE4100361 1991-01-04

Publications (2)

Publication Number Publication Date
AU9010991A AU9010991A (en) 1992-07-16
AU631755B2 true AU631755B2 (en) 1992-12-03

Family

ID=6422686

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90109/91A Ceased AU631755B2 (en) 1991-01-04 1991-12-31 Antidepressant

Country Status (15)

Country Link
EP (1) EP0493861B1 (enExample)
JP (1) JP2519148B2 (enExample)
AT (1) ATE148991T1 (enExample)
AU (1) AU631755B2 (enExample)
BR (1) BR9105183A (enExample)
CA (1) CA2057456C (enExample)
DE (2) DE4100361C1 (enExample)
DK (1) DK0493861T3 (enExample)
ES (1) ES2097181T3 (enExample)
GR (1) GR3022724T3 (enExample)
HU (1) HU213112B (enExample)
IE (1) IE914477A1 (enExample)
NO (1) NO179602C (enExample)
PT (1) PT99962B (enExample)
ZA (1) ZA9244B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
ES2953842B2 (es) * 2023-07-17 2025-02-14 Nuadi Europe S L Tapacubos antipolvo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341412A (en) * 1966-03-04 1967-09-12 Enzomedic Lab Inc Methods of treating schizophrenia
DE58905201D1 (de) * 1988-03-01 1993-09-16 Birkmayer Walther Mittel zur behandlung des parkinson-syndroms.

Also Published As

Publication number Publication date
NO179602C (no) 1996-11-13
AU9010991A (en) 1992-07-16
CA2057456A1 (en) 1992-07-05
ZA9244B (en) 1992-10-28
NO179602B (no) 1996-08-05
DE59108553D1 (de) 1997-03-27
EP0493861B1 (de) 1997-02-19
DK0493861T3 (da) 1997-08-25
IE914477A1 (en) 1992-07-15
BR9105183A (pt) 1992-09-29
DE4100361C1 (enExample) 1992-04-23
EP0493861A3 (en) 1993-03-03
PT99962B (pt) 1999-06-30
CA2057456C (en) 1996-02-06
JPH05139978A (ja) 1993-06-08
ATE148991T1 (de) 1997-03-15
EP0493861A2 (de) 1992-07-08
HU9200025D0 (en) 1992-03-30
GR3022724T3 (en) 1997-06-30
NO920056L (no) 1992-07-06
ES2097181T3 (es) 1997-04-01
NO920056D0 (no) 1992-01-03
PT99962A (pt) 1993-02-26
JP2519148B2 (ja) 1996-07-31
HU213112B (en) 1997-02-28
HUT60141A (en) 1992-08-28

Similar Documents

Publication Publication Date Title
Scharf et al. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
Gillin et al. The cholinergic rapid eye movement induction test with arecoline in depression
Rapoport et al. Childhood enuresis: II. Psychopathology, tricyclic concentration in plasma, and antienuretic effect
PERKINS Combined effects of nicotine and alcohol on subjective, behavioral and physiological responses in humans
WO2013049725A2 (en) Methods of using adenosine a1 receptor activation for treating depression
Aprison et al. Hypersensitive serotonergic receptors: A new hypothesis for one subgroup of unipolar depression derived from an animal model
Raffaele et al. Trazodone therapy of the post-stroke depression
Saletu et al. Fluvoxamine—a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients
Kaur et al. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat
Burke et al. Phenylethanolamine N‐methyltransferase activity is decreased in Alzheimer's disease brains
JPS62106015A (ja) 抗痴呆薬
Menkes Heredodegenerative diseases
AU631755B2 (en) Antidepressant
Curry Concentration‐effect relationships with major and minor tranquilizers
Kimball Factors to be, considered in the control and elimination of chronic tissue soreness beneath dentures
JP2001510800A (ja) 注意欠損／活動亢進症の治療のためのアルカノイルカルニチン誘導体の使用
Schittecatte et al. Reduced clonidine rapid eye movement sleep suppression in patients with primary major affective illness
Knezevic et al. Neuroleptic malignant syndrome
Steiger et al. Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression
Redmond Jr et al. Evoked potential studies of brain catecholamine alterations in monkeys
Havard et al. Adrenal function in hypothyroidism
Wirz-Justice Theoretical and therapeutic potential of indoleamine precursors in affective disorders
Barr et al. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats
Roccaforte et al. Use of psychostimulants for the elderly
US3642994A (en) Therapeutic process using melatonin

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired